MedPath

合肥国药诺和药业有限公司

Ownership
-
Established
2017-12-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20254273
Approval Date
May 27, 2025
NMPA

Ambroxol Hydrochloride Solution For Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
国药准字H20254210
Approval Date
May 20, 2025
NMPA

Potassium Chloride Oral Solution

Product Name
氯化钾口服溶液
Approval Number
国药准字H20253589
Approval Date
Mar 11, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20253599
Approval Date
Mar 11, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20253600
Approval Date
Mar 11, 2025
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20253499
Approval Date
Mar 4, 2025
NMPA

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20249597
Approval Date
Dec 1, 2024
NMPA

Bromhexine Hydrochloride Oral Solution

Product Name
盐酸溴己新口服溶液
Approval Number
国药准字H20244507
Approval Date
Nov 25, 2024
NMPA

Bromhexine Hydrochloride Oral Solution

Product Name
盐酸溴己新口服溶液
Approval Number
国药准字H20244506
Approval Date
Nov 25, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20249342
Approval Date
Nov 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.